Gram Research analysis shows that 68% of breast cancer survivors on hormone therapy in a North African study had metabolic syndrome, a cluster of health problems that raises heart disease risk. However, women who exercised regularly and followed a Mediterranean diet had 56% lower odds of developing this condition for each increase in physical activity level. While this cross-sectional study cannot prove diet and exercise prevent metabolic syndrome, it strongly suggests lifestyle changes may protect cancer survivors’ health during hormone therapy.
A new study of 150 breast cancer survivors in North Africa found that nearly 7 out of 10 women receiving hormone therapy developed metabolic syndrome, a condition that increases the risk of heart disease and diabetes. The good news: women who exercised regularly and followed a Mediterranean diet (rich in vegetables, fish, and olive oil) had significantly lower rates of this condition. The research suggests that lifestyle changes may help protect cancer survivors from serious health complications during and after treatment.
Key Statistics
A cross-sectional study of 150 breast cancer survivors in Algeria found that 68% had metabolic syndrome while receiving hormone therapy, with aromatase inhibitor users showing higher rates of blood sugar problems and high blood pressure compared to tamoxifen users.
According to research reviewed by Gram, breast cancer survivors on hormone therapy who increased physical activity had 56% lower odds of metabolic syndrome for each 0.1-unit increase in physical activity level (95% CI: 0.28-0.68).
A 2026 cross-sectional study of 150 North African women found that higher Mediterranean diet adherence was independently associated with 8% lower odds of metabolic syndrome per point increase on the diet adherence scale.
Among 150 breast cancer survivors on endocrine therapy, aromatase inhibitor users had significantly lower HDL cholesterol and higher fasting glucose levels compared to tamoxifen users, suggesting different metabolic risks by drug type.
The Quick Take
- What they studied: Whether diet and exercise could help prevent metabolic syndrome (a cluster of health problems including high blood pressure, high blood sugar, and unhealthy cholesterol) in breast cancer survivors taking hormone-blocking medications.
- Who participated: 150 women in Algeria who had hormone receptor-positive breast cancer and were taking either tamoxifen or aromatase inhibitors (common hormone therapy drugs). The study ran from May 2022 to December 2025.
- Key finding: About 68% of the women had metabolic syndrome. Those who exercised more and followed a Mediterranean diet had much lower odds of developing this condition. For every small increase in physical activity level, the risk dropped by 56%.
- What it means for you: If you are a breast cancer survivor on hormone therapy, staying active and eating a Mediterranean-style diet may help protect your heart and metabolic health. However, this study shows association, not proof of cause-and-effect, so talk with your doctor about personalized recommendations.
The Research Details
Researchers recruited 150 women in Oran, Algeria who were receiving hormone therapy for breast cancer. Half were taking tamoxifen, and half were taking aromatase inhibitors (drugs that block estrogen). The women completed detailed food records, wore activity monitors, and had blood tests to check for metabolic syndrome (a condition involving high blood pressure, high blood sugar, unhealthy cholesterol, and excess belly fat).
The researchers used a Mediterranean diet questionnaire adapted for North African food culture and measured physical activity using specialized software. They then used statistical methods to see which factors were most strongly linked to metabolic syndrome. The study was observational, meaning researchers watched what happened naturally rather than randomly assigning women to different treatments.
Cross-sectional studies like this one are useful for identifying patterns and connections in real-world populations. By studying women in North Africa specifically, the researchers could see how these issues affect a population that has been understudied in cancer research. The findings suggest that lifestyle interventions might be worth testing in future studies with stronger designs.
The study used validated tools to measure diet and physical activity, and the statistical model performed well (AUC of 0.832, meaning it accurately predicted who had metabolic syndrome). The researchers controlled for multiple factors in their analysis. However, because this is a cross-sectional study, it captures only one moment in time and cannot prove that diet and exercise actually prevent metabolic syndrome. The sample size of 150 is moderate, and the study was conducted in one city, so results may not apply everywhere.
What the Results Show
Metabolic syndrome was extremely common in this group of breast cancer survivors, affecting 68% of participants. This is much higher than rates in the general population. The two hormone therapy drugs had slightly different effects: women taking aromatase inhibitors had lower HDL cholesterol (the good kind), higher blood sugar, and higher blood pressure, while women taking tamoxifen had higher triglycerides (a type of blood fat).
The most important finding was that physical activity and Mediterranean diet adherence were independently protective. For every small increase in physical activity level, the odds of having metabolic syndrome dropped by 56%. Similarly, for every point increase in Mediterranean diet adherence score, the odds dropped by 8%. These associations remained strong even after accounting for age, body weight, and other factors.
The statistical model that combined these factors was quite accurate at predicting who had metabolic syndrome, with a score of 0.832 out of 1.0 (where 1.0 is perfect prediction). This suggests that diet and activity are major players in metabolic health for this population.
The study found that the two hormone therapy drugs affected different aspects of metabolic health. Women on aromatase inhibitors had more problems with blood sugar control and blood pressure, while women on tamoxifen had more problems with triglycerides. This suggests that the type of hormone therapy matters and that different women may need different monitoring and lifestyle strategies. The researchers also noted that sedentary behavior (very low physical activity) was particularly harmful, though the continuous measure of activity was more predictive than simply categorizing women as sedentary or not.
Previous research has shown that metabolic syndrome is common in cancer survivors, but this study is among the first to examine it specifically in North African women on hormone therapy. The high prevalence (68%) is consistent with other studies showing that hormone therapy increases metabolic risk. The protective effects of Mediterranean diet and physical activity align with extensive research in the general population, but this study confirms these benefits apply to cancer survivors as well.
This study has several important limitations. Because it is cross-sectional, it shows associations but cannot prove that diet and exercise actually cause lower metabolic syndrome rates. Women who exercise and eat well may differ in other ways that protect their health. The study included only women in one city in Algeria, so results may not apply to breast cancer survivors in other regions or countries. The researchers could not randomly assign women to different diets or activity levels, so they could not test cause-and-effect. Finally, the study relied on women’s reports of what they ate, which can be inaccurate.
The Bottom Line
Breast cancer survivors on hormone therapy should aim for regular physical activity (at least 150 minutes per week of moderate activity is standard medical advice) and follow a Mediterranean-style diet rich in vegetables, fruits, whole grains, fish, and olive oil. These changes appear to reduce the risk of metabolic syndrome. However, because this study shows association rather than causation, discuss personalized recommendations with your oncologist or cardiologist. Confidence level: Moderate (based on this cross-sectional study plus supporting evidence from other populations).
This research is most relevant to women who have been treated for hormone receptor-positive breast cancer and are taking or have taken tamoxifen or aromatase inhibitors. It may also apply to other cancer survivors on hormone therapy. The findings are less directly applicable to men or to cancer survivors not on hormone therapy, though the general benefits of diet and exercise apply broadly. Anyone with metabolic syndrome should discuss these findings with their doctor.
Changes in physical activity and diet can improve metabolic markers within weeks to months. However, reversing metabolic syndrome completely may take several months to a year of consistent effort. Some benefits (like improved blood pressure) may appear within 2 to 4 weeks, while others (like improved cholesterol) may take 6 to 12 weeks.
Frequently Asked Questions
Do breast cancer survivors on hormone therapy have higher rates of metabolic syndrome?
Yes. This study found that 68% of breast cancer survivors on hormone therapy had metabolic syndrome, a condition involving high blood pressure, high blood sugar, and unhealthy cholesterol. This is much higher than rates in the general population, suggesting hormone therapy increases this risk.
Can diet and exercise help prevent metabolic syndrome in cancer survivors?
This study suggests they may help significantly. Women who exercised more and followed a Mediterranean diet had much lower odds of metabolic syndrome. However, the study shows association, not proof of prevention, so more research is needed to confirm cause-and-effect.
What is the Mediterranean diet and why does it help?
The Mediterranean diet emphasizes vegetables, fruits, whole grains, fish, legumes, and olive oil while limiting red meat and processed foods. It reduces inflammation and improves cholesterol and blood sugar, which are key factors in metabolic syndrome.
How much exercise do breast cancer survivors need to reduce metabolic syndrome risk?
This study measured activity as a continuous variable rather than specifying minutes. Standard medical guidelines recommend 150 minutes of moderate activity weekly. The study suggests that more activity is better, with each increase in activity level reducing metabolic syndrome risk by about 56%.
Do different breast cancer hormone drugs affect metabolic health differently?
Yes. This study found that aromatase inhibitor users had more problems with blood sugar and blood pressure, while tamoxifen users had higher triglycerides. This suggests different drugs carry different metabolic risks and may require different monitoring strategies.
Want to Apply This Research?
- Track weekly minutes of moderate physical activity (aim for 150 minutes) and daily Mediterranean diet adherence using a simple checklist: servings of vegetables, whole grains, fish, olive oil use, and legumes. Log these daily to identify patterns.
- Start with one small change: add a 20-minute walk three times per week, or swap one meal per week for a Mediterranean-style option (like grilled fish with vegetables and olive oil). Build gradually from there rather than trying to overhaul everything at once.
- Every 3 months, reassess physical activity levels and diet quality. If possible, work with your doctor to recheck metabolic markers (blood pressure, cholesterol, blood sugar) every 6 months to see if lifestyle changes are improving your numbers. Use the app to track trends over time.
This research shows associations between diet, exercise, and metabolic syndrome in breast cancer survivors, but does not prove cause-and-effect. The study was conducted in one region and may not apply universally. Breast cancer survivors should consult with their oncologist, cardiologist, or registered dietitian before making significant changes to diet or exercise, especially if they have existing health conditions or are taking medications. This article is for educational purposes and should not replace professional medical advice.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.